{"id":5707,"date":"2021-12-08T08:01:25","date_gmt":"2021-12-08T14:01:25","guid":{"rendered":"http:\/\/pharmgate.com\/usa\/?page_id=5707"},"modified":"2025-10-17T11:41:06","modified_gmt":"2025-10-17T16:41:06","slug":"tulissin-100","status":"publish","type":"page","link":"https:\/\/pharmgate.com\/usa\/tulissin-100\/","title":{"rendered":"Tulissin 100"},"content":{"rendered":"\n<h1>\n\t\tTulissin<sup font-size: 50%;>\u00ae<\/sup> 100\n\t<\/h1>\n\t<h3>(tulathromycin injection)<br \/>\nInjectable Solution<\/h3>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png\" alt=\"Tulissin-species-75x75\" itemprop=\"image\" height=\"75\" width=\"577\" title=\"Tulissin-species-75x75\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t<a href=\"\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/20211025_8838640-LEAFLET-TULISSIN-100-250ML-500ML-US.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tPrescribing Information\n\t\t\t\t\t<\/a>\n\t\t\t<a href=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2025\/10\/Virbac-Tulissin100-Product-Profile-Sheet-10.9.25.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tProduct Profile\n\t\t\t\t\t<\/a>\n\t\t\t<a href=\"\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-100-GHS-SDS-10242021.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tSafety Data Sheet\n\t\t\t\t\t<\/a>\n\t\t\t<a href=\"https:\/\/pharmgate.com\/wp-content\/uploads\/2025\/06\/VIR_Tulissin-100_Swine-Product-Info-Sheet_Pharmgate-Template_FINAL_033022.pdf\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\tTulissin 100 Product Info\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<h4>Product Description<\/h4>\n\t\t\t<p>Tulissin<sup>\u00ae<\/sup>\u00a0100 injectable solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. Each mL of Tulissin<sup>\u00ae<\/sup>\u00a0100 injectable solution contains 100 mg of tulathromycin.<\/p>\n\t\t\t\t\t\t<h4>Key Features<\/h4>\n\t\t\t<h2><strong>Take a New Breath<sup>\u2122<\/sup><\/strong><\/h2>\n<p>Tulissin<sup>\u00ae<\/sup>\u00a0100 (tulathromycin injection) provides a new standard of performance, flexibility and convenience for managing respiratory disease.<\/p>\n<p>Tulathromycin, a first choice therapy<sup>1<\/sup>\u00a0for treating Swine Respiratory Disease (SRD):<\/p>\n<ul>\n<li><strong>Goes to work in minutes<\/strong><sup>2<\/sup><\/li>\n<li>Concentrates in the\u00a0<strong>most susceptible\u00a0<\/strong><strong>areas\u00a0<\/strong>of the respiratory system<\/li>\n<li>Provides\u00a0<strong>nine days\u00a0<\/strong>of lung activity to treat and control SRD<sup>2<\/sup><\/li>\n<li><strong>Convenient dosages\u00a0<\/strong>with availability of Tulissin<sup>\u00ae<\/sup>\u00a025 (tulathromycin injection) for use in smaller pigs with the same pre-slaughter withdraw time of five days<\/li>\n<\/ul>\n<p><strong><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Virbac-blue-box-dosing-Tulissin-100-300x245-1.png\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" srcset=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Virbac-blue-box-dosing-Tulissin-100-300x245-1.png 300w, https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Virbac-blue-box-dosing-Tulissin-100-300x245-1-179x146.png 179w, https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Virbac-blue-box-dosing-Tulissin-100-300x245-1-50x41.png 50w, https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Virbac-blue-box-dosing-Tulissin-100-300x245-1-92x75.png 92w\" alt=\"\" width=\"300\" height=\"245\" \/><\/strong><\/p>\n<strong><br \/>\nTulissin<\/strong><strong><sup>\u00ae<\/sup>\u00a0<\/strong><strong>100 (tulathromycin injection)\u00a0\u00a0\u00a0<\/strong><strong>Tulissin<\/strong><strong><sup>\u00ae<\/sup>\u00a0<\/strong><strong>25 (tulathromycin injection)\u00a0\u00a0<\/strong>\n<p><strong>IMPORTANT SAFETY INFORMATION FOR SWINE<\/strong><\/p>\n<p>Ensure a pre-slaughter withdrawal time of five (5) days in swine. Do not use in animals known to be hypersensitive to the product.<\/p>\n<hr \/>\n<p>Tulissin<sup>\u00ae<\/sup>\u00a0100 (tulathromycin injection)\u00a0a first choice therapy for treating bovine respiratory disease (BRD)<\/p>\n<ul>\n<li><strong>Fast-acting treatment and control<\/strong>\u00a0of bovine respiratory disease (BRD)\n<ul>\n<li><strong>Goes to work in minutes\u00a0<\/strong>to treat and control respiratory disease in high-risk cattle<sup>1<\/sup><\/li>\n<li><strong>Concentrates in the most susceptible areas\u00a0<\/strong>of the respiratory system<sup>5<\/sup><\/li>\n<\/ul>\n<\/li>\n<li><strong>Just one shot<\/strong>\u00a0required for treatment and control with 18-day pre-slaughter withdrawal period<\/li>\n<li>Patented<sup>3\u00a0<\/sup>container design features an easy-grip silicone shell that offers excellent shock- absorption properties. This exclusive packaging protects 250 mL and 500 mL vials against breakage, providing 92% resistance<sup>4<\/sup>\u00a0when dropped multiple times from a height of up to four feet.\u00a0<a href=\"https:\/\/qrco.de\/bcKmeo\" target=\"_blank\" rel=\"noopener noreferrer\">See the protective shell in action.<\/a><\/li>\n<\/ul>\n<p><strong>IMPORTANT SAFETY INFORMATION FOR CATTLE<\/strong><\/p>\n<p><strong>Tulissin<\/strong><strong><sup>\u00ae<\/sup><\/strong><strong>\u00a0100 (tulathromycin injection):<\/strong>\u00a0Not for use in humans. Ensure a pre-slaughter withdrawal time of eighteen (18) days in cattle. Do not use in dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and\/or in calves born to these cows. The effects of tulathromycin on bovine reproductive performance, pregnancy and lactation have not been determined. Do not use in animals known to be hypersensitive to the product.<\/p>\n<ol>\n<li>Villarino N, Brown SA, Martin-Jimenez T. Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.\u00a0<em>J Vet Pharmacol. Ther.\u00a0<\/em>2014;37(3):211-221.<\/li>\n<li>Waag TA, Bradford JR, Lucas MJ, et al. Duration of effectiveness of tulathromycin injectable solution in an Actinobacillus pleuropneumoniae respiratory-disease challenge model in swine.\u00a0<em>J Swine Health Prod.\u00a0<\/em>2008;16(3):126-130.<\/li>\n<li>Patent application n\u00b0WO2019201812 Registered international design n\u00b0DM\/103483.<\/li>\n<li>Internal study.<\/li>\n<li>Foster DM, Martin LG, Papich MG. Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin.\u00a0<em>PLoS ONE.\u00a0<\/em>2016;11(2):e149100.<\/li>\n<\/ol>\n\t\t\t\t\t\t<h4>Label Indications and Dosage<\/h4>\n\t\t\t<div class=\"fl-builder-content fl-builder-content-6815 fl-builder-template fl-builder-module-template fl-builder-global-templates-locked\" data-post-id=\"6815\"><div class=\"fl-module fl-module-advanced-accordion fl-node-50a89ljtdorm\" data-node=\"50a89ljtdorm\">\n\t<div class=\"fl-module-content fl-node-content\">\n\t\t\r\n<div class=\"uabb-module-content uabb-adv-accordion \r\n\t\t\t\t\t\tuabb-adv-accordion-collapse\" data-enable_first=\"yes\" role=\"tablist\" >\r\n\t\t<div class=\"uabb-adv-accordion-item\"\r\n\t\t\tdata-index=\"0\">\r\n\t\t<div class=\"uabb-adv-accordion-button uabb-adv-accordion-button50a89ljtdorm uabb-adv-before-text\" aria-selected=\"false\" role=\"tab\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"expandable\">\r\n\t\t\t<div class=\"uabb-adv-accordion-icon-wrap\" ><i class=\"uabb-adv-accordion-button-icon fas fa-plus\"><\/i><\/div>\t\t\t<div class=\"uabb-adv-accordion-button-label\" >Beef And Non-Lactating Dairy Cattle<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t<div class=\"uabb-adv-accordion-content uabb-adv-accordion-content50a89ljtdorm fl-clearfix uabb-accordion-desc uabb-text-editor\" aria-expanded=\"true\" >\r\n\t\t\t<p><strong>Beef and Non-Lactating Dairy Cattle<\/strong><\/p>\n<p><strong>BRD\u00a0<\/strong>\u2013 Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with\u00a0<em>Mannheimia haemolytica, Pasteurella multocida, Histophilus somni,\u00a0<\/em>and\u00a0<em>Mycoplasma bovis<\/em>; and for the control of respiratory disease in cattle at high risk of developing BRD associated with\u00a0<em>Mannheimia haemolytica, Pasteurella multocida, Histophilus somni,\u00a0<\/em>and\u00a0<em>Mycoplasma bovis.<\/em><\/p>\n<p><strong>IBK\u00a0<\/strong>\u2013 Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with\u00a0<em>Moraxella bovis<\/em>.<\/p>\n<p><strong>Foot Rot\u00a0<\/strong>\u2013 Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with\u00a0<em>Fusobacterium necrophorum\u00a0<\/em>and\u00a0<em>Porphyromonas levii<\/em>.<\/p>\n<p><strong>Suckling Calves, Dairy Calves, and Veal Calves<\/strong><\/p>\n<p><strong>BRD\u00a0<\/strong>\u2013 Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of BRD associated with\u00a0<em>M. haemolytica, P. multocida, H. somni,\u00a0<\/em>and\u00a0<em>M. bovis.<\/em><\/p>\n<hr \/>\n<p><strong>DOSAGE AND ADMINISTRATION<\/strong><\/p>\n<p><strong>Cattle<\/strong><\/p>\n<p>Inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg\/kg (1.1 mL\/100 lb) body weight (BW). Do not inject more than 10 mL per injection site.<\/p>\n<p><strong>Table 1. Tulissin<\/strong><sup>\u00ae<\/sup>\u00a0100 Cattle Dosing Guide<\/p>\n<table>\n<tbody>\n<tr>\n<td>Animal Weight (Pounds)<\/td>\n<td>Dose Volume (mL)<\/td>\n<\/tr>\n<tr>\n<td>100<\/td>\n<td>1.1<\/td>\n<\/tr>\n<tr>\n<td>200<\/td>\n<td>2.3<\/td>\n<\/tr>\n<tr>\n<td>300<\/td>\n<td>3.4<\/td>\n<\/tr>\n<tr>\n<td>400<\/td>\n<td>4.5<\/td>\n<\/tr>\n<tr>\n<td>500<\/td>\n<td>5.7<\/td>\n<\/tr>\n<tr>\n<td>600<\/td>\n<td>6.8<\/td>\n<\/tr>\n<tr>\n<td>700<\/td>\n<td>8.0<\/td>\n<\/tr>\n<tr>\n<td>800<\/td>\n<td>9.1<\/td>\n<\/tr>\n<tr>\n<td>900<\/td>\n<td>10.2<\/td>\n<\/tr>\n<tr>\n<td>1000<\/td>\n<td>11.4<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t<\/div>\r\n\t<\/div>\r\n\t\t<div class=\"uabb-adv-accordion-item\"\r\n\t\t\tdata-index=\"1\">\r\n\t\t<div class=\"uabb-adv-accordion-button uabb-adv-accordion-button50a89ljtdorm uabb-adv-before-text\" aria-selected=\"false\" role=\"tab\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"expandable\">\r\n\t\t\t<div class=\"uabb-adv-accordion-icon-wrap\" ><i class=\"uabb-adv-accordion-button-icon fas fa-plus\"><\/i><\/div>\t\t\t<div class=\"uabb-adv-accordion-button-label\" >Swine<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t<div class=\"uabb-adv-accordion-content uabb-adv-accordion-content50a89ljtdorm fl-clearfix uabb-accordion-desc uabb-text-editor\" aria-expanded=\"true\" >\r\n\t\t\t<p><strong>Swine<\/strong><\/p>\n<p>Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with\u00a0<em>Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis,\u00a0<\/em>and\u00a0<em>Mycoplasma hyopneumoniae<\/em>; and for the control of SRD associated with\u00a0<em>Actinobacillus pleuropneumoniae, Pasteurella multocida,\u00a0<\/em>and\u00a0<em>Mycoplasma hyopneumoniae\u00a0<\/em>in groups of pigs where SRD has been diagnosed.<\/p>\n<hr \/>\n<p><strong>DOSAGE AND ADMINISTRATION<\/strong><\/p>\n<p><strong>Swine<\/strong><\/p>\n<p>Inject intramuscularly as a single dose in the neck at a dosage of 2.5 mg\/kg (0.25 mL\/22 lb) BW. Do not inject more than 2.5 mL per injection site.<\/p>\n<p><strong>Table 2.\u00a0<\/strong>Tulissin<sup>\u00ae<\/sup>\u00a0100 Swine Dosing Guide<\/p>\n<table>\n<tbody>\n<tr>\n<td>Animal Weight (Pounds)<\/td>\n<td>Dose Volume (mL)<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td>0.2<\/td>\n<\/tr>\n<tr>\n<td>30<\/td>\n<td>0.3<\/td>\n<\/tr>\n<tr>\n<td>50<\/td>\n<td>0.6<\/td>\n<\/tr>\n<tr>\n<td>70<\/td>\n<td>0.8<\/td>\n<\/tr>\n<tr>\n<td>90<\/td>\n<td>1.0<\/td>\n<\/tr>\n<tr>\n<td>110<\/td>\n<td>1.3<\/td>\n<\/tr>\n<tr>\n<td>130<\/td>\n<td>1.5<\/td>\n<\/tr>\n<tr>\n<td>150<\/td>\n<td>1.7<\/td>\n<\/tr>\n<tr>\n<td>170<\/td>\n<td>1.9<\/td>\n<\/tr>\n<tr>\n<td>190<\/td>\n<td>2.2<\/td>\n<\/tr>\n<tr>\n<td>210<\/td>\n<td>2.4<\/td>\n<\/tr>\n<tr>\n<td>230<\/td>\n<td>2.6<\/td>\n<\/tr>\n<tr>\n<td>250<\/td>\n<td>2.8<\/td>\n<\/tr>\n<tr>\n<td>270<\/td>\n<td>3.1<\/td>\n<\/tr>\n<tr>\n<td>290<\/td>\n<td>3.3<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t<\/div>\r\n\t<\/div>\r\n\t<\/div>\r\n\t<\/div>\n<\/div>\n<\/div><div class=\"uabb-js-breakpoint\" style=\"display: none;\"><\/div>\t\t\n\t\t\t\t\t\t<h4>Withdrawal Period<\/h4>\n\t\t\t<p><strong>RESIDUE WARNINGS<\/strong><\/p>\n<p><strong>Cattle<\/strong><\/p>\n<p>Cattle intended for human consumption must not be slaughtered within 18 days from the last treatment. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and\/or in calves born to these cows.<\/p>\n<p><strong>Swine<\/strong><\/p>\n<p>Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.<\/p>\n\t\t\t\t\t\t<h4>Packaging<\/h4>\n\t\t\t<ul>\n<li>Tulissin<sup>\u00ae<\/sup>100 Injectable Solution is available in the following package sizes:<br \/>\n50 mL vial; 100 mL vial; 250 mL vial; 500 mL vial<\/li>\n<li>New, patented<sup>4<\/sup>\u00a0container design features an easy-grip silicone shell that offers excellent shock absorption properties. The innovative shell helps dramatically reduce the risk of economic loss, environmental contamination and lack of compliance if treatment is stopped.<\/li>\n<li>This exclusive packaging protects 250 mL and 500 mL vials against breakage, providing 92% Resistance<sup>5<\/sup>\u00a0when dropped multiple times from a height of up to four feet.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/qrco.de\/bcKmeo\" target=\"_blank\" rel=\"noopener noreferrer\">See the protective shell in action.<\/a><\/p>\n\t\t\t\t\t\t<h4>Formulation<\/h4>\n\t\t\t<ul>\n<li>100 mg of tulathromycin\/mL<\/li>\n<\/ul>\n\t\t\t\t\t\t<h4>FDA Status<\/h4>\n\t\t\t<p>Approved by FDA under ANADA # 200-669.<\/p>\n\t\t\t\t\t\t<h5>Beef And Non-Lactating Dairy Cattle<\/h5>\n\t\t\t<p><strong>Beef and Non-Lactating Dairy Cattle<\/strong><\/p>\n<p><strong>BRD\u00a0<\/strong>&#8211; Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with\u00a0<em>Mannheimia haemolytica, Pasteurella multocida, Histophilus somni,\u00a0<\/em>and\u00a0<em>Mycoplasma bovis<\/em>; and for the control of respiratory disease in cattle at high risk of developing BRD associated with\u00a0<em>Mannheimia haemolytica, Pasteurella multocida, Histophilus somni,\u00a0<\/em>and\u00a0<em>Mycoplasma bovis.<\/em><\/p>\n<p><strong>IBK\u00a0<\/strong>&#8211; Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with\u00a0<em>Moraxella bovis<\/em>.<\/p>\n<p><strong>Foot Rot\u00a0<\/strong>&#8211; Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with\u00a0<em>Fusobacterium necrophorum\u00a0<\/em>and\u00a0<em>Porphyromonas levii<\/em>.<\/p>\n<p><strong>Suckling Calves, Dairy Calves, and Veal Calves<\/strong><\/p>\n<p><strong>BRD\u00a0<\/strong>&#8211; Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of BRD associated with\u00a0<em>M. haemolytica, P. multocida, H. somni,\u00a0<\/em>and\u00a0<em>M. bovis.<\/em><\/p>\n<hr \/>\n<p><strong>DOSAGE AND ADMINISTRATION<\/strong><\/p>\n<p><strong>Cattle<\/strong><\/p>\n<p>Inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg\/kg (1.1 mL\/100 lb) body weight (BW). Do not inject more than 10 mL per injection site.<\/p>\n<p><strong>Table 1. Tulissin<\/strong><sup>\u00ae<\/sup>\u00a0100 Cattle Dosing Guide<\/p>\n<table>\n<tbody>\n<tr>\n<td>Animal Weight (Pounds)<\/td>\n<td>Dose Volume (mL)<\/td>\n<\/tr>\n<tr>\n<td>100<\/td>\n<td>1.1<\/td>\n<\/tr>\n<tr>\n<td>200<\/td>\n<td>2.3<\/td>\n<\/tr>\n<tr>\n<td>300<\/td>\n<td>3.4<\/td>\n<\/tr>\n<tr>\n<td>400<\/td>\n<td>4.5<\/td>\n<\/tr>\n<tr>\n<td>500<\/td>\n<td>5.7<\/td>\n<\/tr>\n<tr>\n<td>600<\/td>\n<td>6.8<\/td>\n<\/tr>\n<tr>\n<td>700<\/td>\n<td>8.0<\/td>\n<\/tr>\n<tr>\n<td>800<\/td>\n<td>9.1<\/td>\n<\/tr>\n<tr>\n<td>900<\/td>\n<td>10.2<\/td>\n<\/tr>\n<tr>\n<td>1000<\/td>\n<td>11.4<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t\t\t\t\t<h5>Swine<\/h5>\n\t\t\t<p><strong>Swine<\/strong><\/p>\n<p>Tulissin<sup>\u00ae<\/sup>\u00a0100 Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with\u00a0<em>Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis,\u00a0<\/em>and\u00a0<em>Mycoplasma hyopneumoniae<\/em>; and for the control of SRD associated with\u00a0<em>Actinobacillus pleuropneumoniae, Pasteurella multocida,\u00a0<\/em>and\u00a0<em>Mycoplasma hyopneumoniae\u00a0<\/em>in groups of pigs where SRD has been diagnosed.<\/p>\n<hr \/>\n<p><strong>DOSAGE AND ADMINISTRATION<\/strong><\/p>\n<p><strong>Swine<\/strong><\/p>\n<p>Inject intramuscularly as a single dose in the neck at a dosage of 2.5 mg\/kg (0.25 mL\/22 lb) BW. Do not inject more than 2.5 mL per injection site.<\/p>\n<p><strong>Table 2.\u00a0<\/strong>Tulissin<sup>\u00ae<\/sup>\u00a0100 Swine Dosing Guide<\/p>\n<table>\n<tbody>\n<tr>\n<td>Animal Weight (Pounds)<\/td>\n<td>Dose Volume (mL)<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td>0.2<\/td>\n<\/tr>\n<tr>\n<td>30<\/td>\n<td>0.3<\/td>\n<\/tr>\n<tr>\n<td>50<\/td>\n<td>0.6<\/td>\n<\/tr>\n<tr>\n<td>70<\/td>\n<td>0.8<\/td>\n<\/tr>\n<tr>\n<td>90<\/td>\n<td>1.0<\/td>\n<\/tr>\n<tr>\n<td>110<\/td>\n<td>1.3<\/td>\n<\/tr>\n<tr>\n<td>130<\/td>\n<td>1.5<\/td>\n<\/tr>\n<tr>\n<td>150<\/td>\n<td>1.7<\/td>\n<\/tr>\n<tr>\n<td>170<\/td>\n<td>1.9<\/td>\n<\/tr>\n<tr>\n<td>190<\/td>\n<td>2.2<\/td>\n<\/tr>\n<tr>\n<td>210<\/td>\n<td>2.4<\/td>\n<\/tr>\n<tr>\n<td>230<\/td>\n<td>2.6<\/td>\n<\/tr>\n<tr>\n<td>250<\/td>\n<td>2.8<\/td>\n<\/tr>\n<tr>\n<td>270<\/td>\n<td>3.1<\/td>\n<\/tr>\n<tr>\n<td>290<\/td>\n<td>3.3<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/TULISSIN-100_500ml_Bottle_WEB_600X600_right.png\" alt=\"TULISSIN 100_500ml_Bottle_WEB_600X600_right\" itemprop=\"image\" height=\"600\" width=\"600\" title=\"TULISSIN 100_500ml_Bottle_WEB_600X600_right\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Virbac-logo-125x60.png\" alt=\"Virbac-logo-125x60\" itemprop=\"image\" height=\"60\" width=\"125\" title=\"Virbac-logo-125x60\" onerror=\"this.style.display='none'\"  \/>\n\t<p>Produced by Virbac<\/p>\n\t<h4><strong><a href=\"https:\/\/vet-us.virbac.com\/home\/livestock-health\/tulissin-100-tulathromycin-injection.html\" target=\"_blank\" rel=\"noopener noreferrer\">Click to<br \/>\nlearn more<br \/>\nfrom Virbac.<\/a><\/strong><\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2017\/12\/usa-75x75.png\" alt=\"usa-75x75\" itemprop=\"image\" height=\"74\" width=\"75\" title=\"usa-75x75\" onerror=\"this.style.display='none'\"  \/>\n\t<p>Available in the USA<\/p>\n\t<p><em>The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.<\/em><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Tulissin\u00ae 100 (tulathromycin injection) Injectable Solution Prescribing Information Product Profile Safety Data Sheet Tulissin 100 Product Info Product Description Tulissin\u00ae\u00a0100 injectable solution is a ready-to-use<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/fullwidthpage.php","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"country":[],"producttype":[],"species":[],"class_list":["post-5707","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Tulissin 100 - USA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmgate.com\/usa\/tulissin-100\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tulissin 100 - USA\" \/>\n<meta property=\"og:description\" content=\"Tulissin\u00ae 100 (tulathromycin injection) Injectable Solution Prescribing Information Product Profile Safety Data Sheet Tulissin 100 Product Info Product Description Tulissin\u00ae\u00a0100 injectable solution is a ready-to-use\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmgate.com\/usa\/tulissin-100\/\" \/>\n<meta property=\"og:site_name\" content=\"USA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-17T16:41:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pharmgate.com\/usa\/tulissin-100\/\",\"url\":\"https:\/\/pharmgate.com\/usa\/tulissin-100\/\",\"name\":\"Tulissin 100 - USA\",\"isPartOf\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/tulissin-100\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/tulissin-100\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png\",\"datePublished\":\"2021-12-08T14:01:25+00:00\",\"dateModified\":\"2025-10-17T16:41:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pharmgate.com\/usa\/tulissin-100\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pharmgate.com\/usa\/tulissin-100\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pharmgate.com\/usa\/tulissin-100\/#primaryimage\",\"url\":\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png\",\"contentUrl\":\"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pharmgate.com\/usa\/tulissin-100\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pharmgate.com\/usa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tulissin 100\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pharmgate.com\/usa\/#website\",\"url\":\"https:\/\/pharmgate.com\/usa\/\",\"name\":\"USA\",\"description\":\"USA\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pharmgate.com\/usa\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tulissin 100 - USA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmgate.com\/usa\/tulissin-100\/","og_locale":"en_US","og_type":"article","og_title":"Tulissin 100 - USA","og_description":"Tulissin\u00ae 100 (tulathromycin injection) Injectable Solution Prescribing Information Product Profile Safety Data Sheet Tulissin 100 Product Info Product Description Tulissin\u00ae\u00a0100 injectable solution is a ready-to-use","og_url":"https:\/\/pharmgate.com\/usa\/tulissin-100\/","og_site_name":"USA","article_modified_time":"2025-10-17T16:41:06+00:00","og_image":[{"url":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pharmgate.com\/usa\/tulissin-100\/","url":"https:\/\/pharmgate.com\/usa\/tulissin-100\/","name":"Tulissin 100 - USA","isPartOf":{"@id":"https:\/\/pharmgate.com\/usa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharmgate.com\/usa\/tulissin-100\/#primaryimage"},"image":{"@id":"https:\/\/pharmgate.com\/usa\/tulissin-100\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png","datePublished":"2021-12-08T14:01:25+00:00","dateModified":"2025-10-17T16:41:06+00:00","breadcrumb":{"@id":"https:\/\/pharmgate.com\/usa\/tulissin-100\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmgate.com\/usa\/tulissin-100\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmgate.com\/usa\/tulissin-100\/#primaryimage","url":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png","contentUrl":"https:\/\/pharmgate.com\/usa\/wp-content\/uploads\/sites\/5\/2021\/12\/Tulissin-species-75x75.png"},{"@type":"BreadcrumbList","@id":"https:\/\/pharmgate.com\/usa\/tulissin-100\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharmgate.com\/usa\/"},{"@type":"ListItem","position":2,"name":"Tulissin 100"}]},{"@type":"WebSite","@id":"https:\/\/pharmgate.com\/usa\/#website","url":"https:\/\/pharmgate.com\/usa\/","name":"USA","description":"USA","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmgate.com\/usa\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/pages\/5707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/comments?post=5707"}],"version-history":[{"count":39,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/pages\/5707\/revisions"}],"predecessor-version":[{"id":10673,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/pages\/5707\/revisions\/10673"}],"wp:attachment":[{"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/media?parent=5707"}],"wp:term":[{"taxonomy":"country","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/country?post=5707"},{"taxonomy":"producttype","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/producttype?post=5707"},{"taxonomy":"species","embeddable":true,"href":"https:\/\/pharmgate.com\/usa\/wp-json\/wp\/v2\/species?post=5707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}